Kiora Pharmaceuticals (NASDAQ:KPRX) focuses on developing advanced therapeutic solutions aimed at treating eye diseases. Their operations involve extensive research and innovation to address significant unmet needs in ophthalmology. The company's projects are designed to explore novel pathways for treating conditions such as dry eye syndrome, uveitis, and other ocular disorders, with the ultimate objective of improving patients' quality of life. Kiora is dedicated to pushing the boundaries of science to bring forward new, efficacious treatments that can alleviate the burdens of eye diseases on patients worldwide. Their commitment to excellence drives their pursuit of groundbreaking discoveries in the field of eye health.